Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LAURION Intercepts of 37.70 g/t Gold over 0.50 m, 6.60 g/t Gold over 1.00 m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Avadel Pharmaceuticals PLC AVDL

Healthcare Biotechnology
Avadel Pharmaceuticals PLC is a biopharmaceutical company. The Company's product, LUMRYZ, is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or excessive daytime sleepiness (EDS) in adults with narcolepsy. Its approach includes applying solutions to the development of medications that address the patients face with treatment... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:AVDL)

Results from Social Listening Analysis and Survey of People with Narcolepsy Uncover Real-Life Challenges with Twice-Nightly Oxybate Therapy

GlobeNewswire 1 hour ago

Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference

GlobeNewswire November 13, 2024

Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results

GlobeNewswire November 12, 2024

Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12

GlobeNewswire November 4, 2024

Avadel Pharmaceuticals Announces Favorable Ruling in Administrative Procedure Act Litigation

GlobeNewswire October 31, 2024

Avadel Pharmaceuticals and nference Announce Publication of Real-World Data in Sleep Advances

GlobeNewswire October 24, 2024

Avadel Pharmaceuticals Announces FDA Approval of LUMRYZ(TM) (sodium oxybate) Extended-Release Oral Suspension (CIII) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Patients 7 Years of Age and Older with Narcolepsy

GlobeNewswire October 17, 2024

Avadel Pharmaceuticals Announces Publication of Data Highlighting Efficacy of LUMRYZ(TM) (sodium oxybate) Extended-Release Oral Suspension in Improving Narcolepsy Symptoms Regardless of Concomitant Use of an Alerting Agent

GlobeNewswire September 25, 2024

Avadel Pharmaceuticals Announces Publication of RESTORE Data Highlighting Challenges with Twice-Nightly Oxybates and Strong Patient Preference for Once-Nightly LUMRYZ(TM) Dosing (sodium oxybate) Extended-Release Oral Suspension (CIII)

GlobeNewswire September 3, 2024
View More News ››

Opinion & Analysis (NDAQ:AVDL)

Avadel Shares Rise and Shine on Positive Phase 3 Narcolepsy Study Findings

Streetwise Reports April 28, 2020

Avadel Pharma Shares Up 30% Upon Acceleration of Phase 3 REST-ON Study

Streetwise Reports September 24, 2019
View More Opinion ››

Bullboard Posts (NDAQ:AVDL)

Be the first to post on this bullboard.

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical ...
View More »